Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Tesla
TSLA
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 7.430
- +0.290+4.06%
Close Apr 24 16:00 ET
- 7.450
- +0.020+0.27%
Post 16:53 ET
792.26MMarket Cap-2.72P/E (TTM)
7.500High7.105Low2.27MVolume7.150Open7.140Pre Close16.68MTurnover2.81%Turnover RatioLossP/E (Static)106.63MShares26.98052wk High1.71P/B600.22MFloat Cap4.55052wk Low--Dividend TTM80.78MShs Float67.480Historical High--Div YieldTTM5.53%Amplitude4.550Historical Low7.351Avg Price1Lot Size
Rocket Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.60%-209.72M | -60.00%-46.94M | 8.83%-52.1M | -5.81%-53.82M | 1.22%-56.86M | -9.42%-194.92M | 47.63%-29.34M | -30.30%-57.15M | -30.30%-50.87M | -46.75%-57.56M |
| Net income from continuing operations | -5.35%-258.75M | -1.12%-60.33M | -7.79%-66.72M | -6.00%-69.65M | -6.38%-62.05M | -10.70%-245.6M | 10.59%-59.66M | -7.17%-61.9M | -20.77%-65.7M | -35.72%-58.34M |
| Operating gains losses | 615.38%1.88M | ---- | ---- | ---- | ---- | ---364K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 32.08%9.38M | 22.02%2.36M | 35.82%2.39M | 36.97%2.37M | 34.73%2.25M | 13.28%7.1M | 8.83%1.94M | 8.58%1.76M | 10.54%1.73M | 28.49%1.67M |
| Change In working capital | -86.12%1.92M | -103.28%-717K | 147.58%2.83M | -18.38%4.36M | 39.04%-4.55M | 127.49%13.82M | 12,777.65%21.89M | -233.72%-5.94M | -9.29%5.34M | -68.62%-7.47M |
| -Change in prepaid assets | -124.54%-661K | -92.40%354K | 93.86%-286K | -76.97%422K | -232.91%-1.15M | 174.98%2.69M | 301.12%4.66M | -2,302.06%-4.66M | -35.76%1.83M | 122.00%866K |
| -Change in payables and accrued expense | -40.21%6.07M | -95.09%774K | 379.63%3.17M | 38.56%4.54M | 68.86%-2.41M | 4.89%10.15M | 534.12%15.76M | -124.43%-1.13M | 7.70%3.27M | -1,478.41%-7.75M |
| -Change in other current liabilities | -455.45%-3.49M | -224.83%-1.85M | 62.00%-57K | -348.95%-595K | -68.94%-990K | 19,720.00%981K | --1.48M | -7,400.00%-150K | --239K | -19,433.33%-586K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.60%-209.72M | -60.00%-46.94M | 8.83%-52.1M | -5.81%-53.82M | 1.22%-56.86M | -9.42%-194.92M | 47.63%-29.34M | -30.30%-57.15M | -30.30%-50.87M | -46.75%-57.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 234.30%131.71M | 73.10%-37.87M | 63.55%78.92M | 78.25%55.62M | 195.41%35.03M | -41.46%-98.07M | -29.67%-140.81M | 105.64%48.25M | -60.39%31.21M | 41.71%-36.72M |
| Net PPE purchase and sale | 64.41%-5.86M | 93.35%-309K | 65.89%-1.59M | 53.47%-1.93M | 32.66%-2.04M | -91.11%-16.47M | -42.37%-4.65M | -825.45%-4.66M | -43.18%-4.15M | -54.58%-3.02M |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | 268.60%137.57M | 72.41%-37.56M | 52.16%80.51M | 62.79%57.55M | 210.00%37.07M | 21.11%-81.59M | 8.03%-136.16M | 120.75%52.91M | -56.72%35.35M | 44.79%-33.7M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 234.30%131.71M | 73.10%-37.87M | 63.55%78.92M | 78.25%55.62M | 195.41%35.03M | -41.46%-98.07M | -29.67%-140.81M | 105.64%48.25M | -60.39%31.21M | 41.71%-36.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10.87%185.74M | 46,664.45%182.85M | -99.91%176K | 740.66%1.53M | -93.55%1.18M | 34.20%208.4M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,035.53%18.34M |
| Net common stock issuance | -10.87%185.74M | 46,664.45%182.85M | -99.91%176K | 740.66%1.53M | -93.54%1.18M | 34.20%208.39M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,026.32%18.34M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | --7K | --0 | --0 | --0 | --7K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10.87%185.74M | 46,664.45%182.85M | -99.91%176K | 740.66%1.53M | -93.55%1.18M | 34.20%208.4M | -99.64%391K | 541.76%189.49M | -98.94%182K | 24,035.53%18.34M |
| Net cash flow | ||||||||||
| Beginning cash position | -59.62%57.28M | -70.51%66.96M | -13.93%39.97M | -44.42%36.64M | -59.62%57.28M | -39.39%141.86M | 14.65%227.03M | -75.42%46.44M | -50.02%65.92M | -39.39%141.86M |
| Current changes in cash | 227.36%107.72M | 157.75%98.04M | -85.05%26.99M | 117.10%3.33M | 72.82%-20.64M | 8.24%-84.58M | -202.23%-169.75M | 1,877.56%180.59M | -134.18%-19.48M | 25.65%-75.94M |
| End cash Position | 188.07%165M | 188.07%165M | -70.51%66.96M | -13.93%39.97M | -44.42%36.64M | -59.62%57.28M | -59.62%57.28M | 14.65%227.03M | -75.42%46.44M | -50.02%65.92M |
| Free cash flow | -1.99%-215.59M | -39.03%-47.25M | 13.13%-53.69M | -1.34%-55.75M | 2.79%-58.89M | -13.19%-211.39M | 42.67%-33.99M | -39.32%-61.8M | -31.19%-55.02M | -47.12%-60.58M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call